SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-015749
Filing Date
2019-03-04
Accepted
2019-03-04 17:12:10
Documents
1
Period of Report
2019-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5218
  Complete submission text file 0001209191-19-015749.txt   6619
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2200 PENNSYLVANIA AVENUE SUITE 300E WASHINGTON DC 20037
Business Address
Reverberi Gian Piero (Reporting) CIK: 0001652023 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 19654988